Tish Eggleston Pahl will be speaking on May 19 at a webinar on dispenser obligations under the Drug Supply Chain Security Act (DSCSA). The webinar is sponsored by the Healthcare Distribution Management Association (HDMA). This “DSCSA Overview…
Read More
The passage of the Drug Supply Chain Security Act (DSCSA) in November 2013 led to a very busy 2014 as FDA and manufacturers, wholesale distributors, and dispensers began the statute’s complex 10-year implementation. 2015 promises to be equally bu…
Read More
Tags: 3PL, CDER, Drug, Drug Dispenser, Drug Supply Chain Security Act, DSCSA, FDA, Interoperable Exchange, Prescription Drug, Repackager, Third-Party, Tish Eggleston Pahl, Wholesale Drug Distributor
In a flurry of end-of-year activity, FDA recently issued a Draft Guidance on the express preemption provisions in §585 of the FDC Act, added last year by the Drug Supply Chain Security Act (or DSCSA). FDA, the pharmaceutical supply chain, and other…
Read More
Tags: 3PL, Congress, Drug, Drug Dispenser, Drug Supply Chain, Drug Supply Chain Security Act, DSCSA, Energy and Commerce, FDA, Guidance, Logistics Provider, Pre-emption, Preemption, Third-Party, Tish Eggleston Pahl, VAWD, Wholesale, Wholesale Drug Distributor
A Complimentary Webinar Presented by OFW Law’s Tish Pahl and the Food Marketing Institute
Thursday, December 4th, 2014
3:00 pm – 4:00 pm US/Eastern
Please join FMI on a webinar with Tish Pahl —Under the Drug Supply Chain Security Act (D…
Read More
Tags: Drug, Drug Dispenser, Drug Supply Chain, DSCSA, FDA, FMI, Food Marketing Institute, OFW Law, Prescription Drug, Tish Eggleston Pahl, Transaction Data, Webinar, Wholesale, Wholesale Drug Distributor
While you were sitting in traffic, making pie crust, or absorbing the menu and vending labeling rules…
FDA Opens Portal For Wholesale Distributor and 3PL Reporting
At OFW Law, we hope you all had a terrific Thanksgiving. (If you followed the advi…
Read More
Tags: 3PL, CDER, Center for Drug Evaluation and Research, Direct Electronic Submissions Portal, Drug, Drug Supply Chain, DSCSA, FDA, Logistics Provider, Third-Party, Tish Eggleston Pahl, Wholesale, Wholesale Drug Distributor
This morning, FDA met another of its milestones in implementing the Drug Supply Chain Security Act (DSCSA) and posted a Draft Guidance, DSCSA Standards for the Interoperable Exchange of Information for Tracing of Certain Human, Finished, Prescription…
Read More
OFW Law Celebrates 35 Years of Successes in Drug/Healthcare Privacy Practices (Part IV)
By Tish Eggleston Pahl
In celebrating 35 years of practice, OFW Law’s Drugs, Biologics, and Controlled Substances and Healthcare Privacy practice groups are ta…
Read More
Tags: Congress, Drug, Drug Quality and Security Act, Drug Sample, Drug Supply Chain, Drug Supply Chain Security Act, DSCSA, FDA, OFW Law, PDMA, Prescription Drug, Prescription Drug Marketing Act, Tish Eggleston Pahl, Traceability, Wholesale, Wholesale Drug Distributor
In a time when internecine conflicts within the Congress and between the legislative and executive branch stymie so much important work, the easy passage of the bipartisan Drug Quality and Security Act (DQSA) (H.R. 3204) is cause for celebration. H…
Read More
Tags: Compounding Pharmacies, Drug Dispenser, Drug Manufacturer, Drug Quality and Security Act, Food Drug and Cosmetic Act, HR 3204, Meningitis Outbreak, National Drug Code, Prescription Drug, Product Identifier, Standardized Numerical Identifier, Tish Eggleston Pahl, Wholesale Drug Distributor
As I write this, my Labrador is gutting a stuffed mouse at my feet. I’ll need to take the toy from her shortly to avoid her enthusiastic consumption of the squeaker within (and what I know, from experience, can be a very costly aftermath of emer…
Read More
Tags: Consumers, FDA Compliance, FTC, FTC Enforcement, Generic Drug, Pet Medication, Prescription Drug, Proposed Regulation, Social Media, Tish Eggleston Pahl, Veterinarian, Wholesale Drug Distributor
OFW Law’s Drug and Health Care Privacy Practices focus on advising our clients regarding every aspect of the regulatory process related to bringing a product to market, post-marketing compliance, and issues central to the privacy of personal health…
Read More
Tags: Advertising, Congress, Cosmetics, DEA, Drug, Drug Approval, Drug Marketing, FDA Compliance, FDA Enforcement, Food Drug and Cosmetic Act, Healthcare, Jonathan M. Weinrieb, Labeling, New Drug Application, OTC Drugs, Prescription Drug, Privacy, Public Policy, State Law, Wholesale Drug Distributor
